Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0IN7R
|
|||
| Drug Name |
MUC-1 CART cell immunotherapy
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Intrahepatic cholangiocarcinoma [ICD-11: 2C12.10; ICD-10: C22.1; ICD-9: 155.1, 156.1] | Phase 1/2 | [1] | |
| Company |
Second Affiliated Hospital, School of Medicine, Zhejiang University
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mucin-1 (MUC1) | Target Info | CAR-T-Cell-Therapy | [1] |
| WikiPathways | Hematopoietic Stem Cell Differentiation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03633773) Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.